These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8883280

  • 1. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
    Rallidis LS, Megalou AA, Papageorgakis NH, Trikas AG, Chatzidimitriou GI, Tsitouris GK.
    Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280
    [Abstract] [Full Text] [Related]

  • 2. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study Group.
    Bara L, Nicaud V, Tiret L, Cambien F, Samama MM.
    Thromb Haemost; 1994 Apr; 71(4):434-40. PubMed ID: 8052959
    [Abstract] [Full Text] [Related]

  • 3. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M, Zegura B, Guzic-Salobir B, Keber I.
    Wien Klin Wochenschr; 2001 Feb 15; 113(3-4):113-8. PubMed ID: 11253736
    [Abstract] [Full Text] [Related]

  • 4. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr 15; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
    Oseroff A, Krishnamurti C, Hassett A, Tang D, Alving B.
    J Lab Clin Med; 1989 Jan 15; 113(1):88-93. PubMed ID: 2783330
    [Abstract] [Full Text] [Related]

  • 6. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I.
    Thromb Haemost; 1998 Nov 15; 80(5):749-56. PubMed ID: 9843166
    [Abstract] [Full Text] [Related]

  • 7. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C.
    Thromb Haemost; 2001 Nov 15; 86(5):1197-203. PubMed ID: 11816707
    [Abstract] [Full Text] [Related]

  • 8. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J, Skrha J, Perusicová J, Maslowská H, Pochopová L.
    Cas Lek Cesk; 1996 Mar 20; 135(6):174-7. PubMed ID: 8681360
    [Abstract] [Full Text] [Related]

  • 9. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 10. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR.
    Thromb Haemost; 1988 Dec 22; 60(3):372-6. PubMed ID: 3149044
    [Abstract] [Full Text] [Related]

  • 11. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK, Cooper JA, Howarth DJ, Meade TW, Miller GJ.
    Thromb Haemost; 1998 Mar 22; 79(3):587-90. PubMed ID: 9531046
    [Abstract] [Full Text] [Related]

  • 12. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L, Bergerone S, Gambino R, Imazio M, Macchia G, Cravetto A, Gaschino G, Baralis G, Rosettani E, Pagano G, Cassader M.
    Nutr Metab Cardiovasc Dis; 1999 Jun 22; 9(3):118-24. PubMed ID: 10464784
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep 22; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 14. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R, Velmurugan K, Saravanan G, Dwarakanath V, Agarwal S, Mohan V.
    J Assoc Physicians India; 2002 Jul 22; 50():901-6. PubMed ID: 12126344
    [Abstract] [Full Text] [Related]

  • 15. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T.
    J Lab Clin Med; 1993 Oct 22; 122(4):412-20. PubMed ID: 8228555
    [Abstract] [Full Text] [Related]

  • 16. Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.
    Väisänen S, Baumstark MW, Penttilä I, Bouchard C, Halonen P, Rankinen T, Berg A, Rauramaa R.
    Thromb Haemost; 1997 Dec 22; 78(6):1495-9. PubMed ID: 9423801
    [Abstract] [Full Text] [Related]

  • 17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 22; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 18. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 22; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 19. Elevation of plasma fibrinogen in silent myocardial ischaemia.
    Grzywacz A, Psuja P, Zozulińska M, Elikowski W, Zawilska K.
    Acta Biochim Pol; 1999 Mar 22; 46(4):985-9. PubMed ID: 10824869
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May 22; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.